Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Immunotech Biopharm Ltd ( (HK:6978) ) just unveiled an update.
Immunotech Biopharm Ltd has announced a change in its board of directors, effective from October 16, 2025. Mr. Cao Ran has been appointed as a non-executive director and a member of the audit committee, bringing extensive experience in pharmaceutical production management. Concurrently, Ms. Yu Xiaohui has resigned from her position due to other job arrangements. The company has expressed gratitude for Ms. Yu’s contributions and warmly welcomed Mr. Cao, which may impact the company’s strategic direction and governance.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a company incorporated in the Cayman Islands, focusing on the biopharmaceutical industry. It operates through its subsidiaries and is listed on the Hong Kong Stock Exchange, engaging in the development and production of pharmaceutical products.
Average Trading Volume: 1,295,038
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.62B
See more insights into 6978 stock on TipRanks’ Stock Analysis page.